EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
批准号:
10383202
负责人:
Jeffrey Wigdahl
金额:
$24.76万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-11-30
关键词:
AgreementAreaArtificial IntelligenceCaringCellular PhoneClassificationClinicalComputer softwareConsultationsDetectionDevelopmentDevicesDiabetic RetinopathyDiagnosisDiagnosticDiseaseDisease ProgressionDisease regressionDocumentationEnsureEyeFutureGenerationsGoalsGrantImageImage AnalysisJointsLegal patentLesionLettersLicensingMacular degenerationMalariaManufacturer NameMeasuresMethodsOphthalmologistOphthalmoscopesOphthalmoscopyOptometristPaperPathologyPatientsPhasePriceProceduresRecordsRetinaRetinal DiseasesRetinopathy of PrematuritySoftware ToolsSpecialistTechniquesTestingTimeUnited StatesVideo RecordingVisualWorkbaseclinical carecostdesigndiagnostic tooldigitalexperienceimage processingimage registrationimprovedinnovationlenslongitudinal analysisretinal imagingscreeningskillssoftware developmentsuccesstime usetool
中文摘要
摘要
拟议项目的目标是开发EyeStar-BIO,这是一套软件工具,旨在增强数字
双目间接检眼镜检查(BIO),是眼底疾病最常见的检查形式之一。
视网膜。使用BIO,眼科医生可以确定多种视网膜疾病的存在,如糖尿病
视网膜病变、黄斑变性、早产儿视网膜病变等。传统的生物考试
不生成任何可视文档。
EyeStar-Bio将提供目前未作为数字生物考试一部分提供的创新功能:(1)
自动图像质量评估,(2)自动拼接以创建大视野的视网膜,(3)
纵向分析;(4)基于人工智能的疾病检测。该项目有8亿美元的市场潜力作为生物
检查仍然是眼科医生最常见的程序之一。
这个第一阶段项目的目标将通过三个具体目标来实现。目标1:实施软件以
数字生物视频帧的自动图像质量评估。目标2:开发图像拼接方法以
使用视频中质量最好的帧生成视网膜的大视野。目标3:生成图像以
跟踪由于疾病进展或退化而产生的时间差异。
EyeStar-BIO软件将授权给数字BIO耳机制造商。未来的发展将
包括EyeStar-Bio实时实施和使用人工视网膜诊断视网膜疾病的能力
智慧。
英文摘要
Summary
The goal of the proposed project is to develop EyeStar-BIO, a suite of software tools designed to enhance digital
binocular indirect ophthalmoscopy examinations (BIO), one of the most common forms of examination of the
retina. Using BIO, an ophthalmologist can determine the presence of multiple retinal diseases such as diabetic
retinopathy, macular degeneration, and retinopathy of prematurity, among others. The traditional BIO exam
does not produce any visual documentation.
EyeStar-BIO will feature innovative features that are not currently offered as part of digital BIO exams: (1)
automatic image quality assessment, (2) automatic stitching to create a wide-field view of the retina, (3)
longitudinal analysis, and (4) AI-based disease detection. This project has an $800M market potential as BIO
examinations remain one of the most common procedures for ophthalmologists.
The goals of this Phase I project will be accomplished via three specific aims. Aim 1: implement software for
automatic image quality assessment of digital BIO video frames. Aim 2: develop image stitching methods to
generate a wide field view of the retina using the best quality frames in the video. Aim 3: generate images to
track differences in time due to disease progression or regression.
The EyeStar-BIO software will be licensed to manufacturers of digital BIO headsets. Future developments will
include real time implementations of EyeStar-BIO and the ability to diagnose retinal disease using artificial
intelligence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
-
批准号:10824075
-
项目类别:
-
资助金额:$5.45万
-
财政年份:2022
-
负责人:Jeffrey Wigdahl
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: